ALZN financials
Alzamend Neuro (ALZN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ALZN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2026 | – | – | -$8.77M | -$8.77M | -2.63 |
| 2025 | – | – | -$4.50M | -$5.11M | -11.32 |
| 2024 | – | – | -$9.94M | -$9.95M | -132.33 |
| 2023 | – | – | -$14.87M | -$14.88M | -228.90 |
| 2022 | – | – | -$12.32M | -$12.36M | -21.00 |
| 2021 | – | – | -$4.95M | -$5.05M | -10.50 |